Cargando…
Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
OBJECTIVE: The objective of this theoretical paper is to identify conceptual solutions for securing, predicting, and improving vaccine production and supply chains. METHOD: The case study, action research, and review method is used with secondary data – publicly available open access data. RESULTS:...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811889/ https://www.ncbi.nlm.nih.gov/pubmed/36620395 http://dx.doi.org/10.1007/s12553-022-00722-2 |
_version_ | 1784863620267507712 |
---|---|
author | Radanliev, Petar De Roure, David |
author_facet | Radanliev, Petar De Roure, David |
author_sort | Radanliev, Petar |
collection | PubMed |
description | OBJECTIVE: The objective of this theoretical paper is to identify conceptual solutions for securing, predicting, and improving vaccine production and supply chains. METHOD: The case study, action research, and review method is used with secondary data – publicly available open access data. RESULTS: A set of six algorithmic solutions is presented for resolving vaccine production and supply chain bottlenecks. A different set of algorithmic solutions is presented for forecasting risks during a Disease X event. A new conceptual framework is designed to integrate the emerging solutions in vaccine production and supply chains. The framework is constructed to improve the state-of-the-art by intersecting the previously isolated disciplines of edge computing; cyber-risk analytics; healthcare systems, and AI algorithms. CONCLUSION: For healthcare systems to cope better during a disease X event than during Covid-19, we need multiple highly specific AI algorithms, targeted for solving specific problems. The proposed framework would reduce production and supply chain risk and complexity in a Disease X event. |
format | Online Article Text |
id | pubmed-9811889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98118892023-01-04 Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 Radanliev, Petar De Roure, David Health Technol (Berl) Review Paper OBJECTIVE: The objective of this theoretical paper is to identify conceptual solutions for securing, predicting, and improving vaccine production and supply chains. METHOD: The case study, action research, and review method is used with secondary data – publicly available open access data. RESULTS: A set of six algorithmic solutions is presented for resolving vaccine production and supply chain bottlenecks. A different set of algorithmic solutions is presented for forecasting risks during a Disease X event. A new conceptual framework is designed to integrate the emerging solutions in vaccine production and supply chains. The framework is constructed to improve the state-of-the-art by intersecting the previously isolated disciplines of edge computing; cyber-risk analytics; healthcare systems, and AI algorithms. CONCLUSION: For healthcare systems to cope better during a disease X event than during Covid-19, we need multiple highly specific AI algorithms, targeted for solving specific problems. The proposed framework would reduce production and supply chain risk and complexity in a Disease X event. Springer Berlin Heidelberg 2023-01-04 2023 /pmc/articles/PMC9811889/ /pubmed/36620395 http://dx.doi.org/10.1007/s12553-022-00722-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Paper Radanliev, Petar De Roure, David Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
title | Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
title_full | Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
title_fullStr | Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
title_full_unstemmed | Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
title_short | Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
title_sort | disease x vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811889/ https://www.ncbi.nlm.nih.gov/pubmed/36620395 http://dx.doi.org/10.1007/s12553-022-00722-2 |
work_keys_str_mv | AT radanlievpetar diseasexvaccineproductionandsupplychainsriskassessinghealthcaresystemsoperatingwithartificialintelligenceandindustry40 AT derouredavid diseasexvaccineproductionandsupplychainsriskassessinghealthcaresystemsoperatingwithartificialintelligenceandindustry40 |